Telemedicine Creating an Incredible $175 Billion Long-Term Opportunity May 07, 2020 - Baystreet.ca With the coronavirus making its rounds, telemedicine is under big demand. All as government and health officials advise against face to face meetings. It’s becoming so popular Global Market Insights estimates the market could be worth $175 billion by 2026. “Maintaining social distancing and self-quarantine are of key importance in containing the spread of corona virus. This have led to few countries taking stringent measures such as partial or complete lockdown. Which supports increasing adoption of telemedicine services to avail healthcare services. Also, various stringent regulations that were imposed on practicing telemedicine have also been relaxed. Such favorable government policies and growing inclination of patients towards virtual visits will propel the telemedicine market growth.” Markets and Markets estimates telehealth could grow from $25.4 billion in 2020 to more than $55.6 billion in 2025. While estimates vary, one thing is for certain. “Virtual care has moved to center stage and I would say it’s taken an irreversible leap forward,” said Teladoc Chief Executive Jason Gorevic. As demand increases some of the top companies leading the charge include CloudMD Software & Services Inc. (CSE:DOC)(OTCQB:DOCRF), Telus (TSX:T)(NYSE:TU), Teladoc Health Inc. (NYSE:TDOC), CVS Health Corp. (NYSE:CVS), and Walgreens Boots Alliance Inc. (NASDAQ:WBA). CloudMD Software & Services Inc. (CSE:DOC)(OTCQB:DOCRF) BREAKING NEWS: CloudMD Software & Services Inc, a telemedicine company revolutionizing the delivery of healthcare to patients, is excited to announce that it has entered into a Value Added Reseller Agreement with IDYA4 Corp., a leader in data interoperability and integration solutions within the government and private sectors. Under the Agreement, IDYA4 will resell CloudMD’s Livecare technology in the United States. The partnership opens up a significant opportunity for CloudMD to expand its telemedicine platform into the U.S., and IDYA4 subject matter expertise and established client network adds significant value to CloudMD’s expansion plan. The partnership further demonstrates CloudMD’s ability to tap into this multi-billion-dollar industry as an emerging leader in providing virtual healthcare. IDYA4 provides revolutionary technology solutions within public safety, corrections, health and human services sectors. IDYA4 has an impressive portfolio of clients including, the Bureau of Justice Assistance, U.S. Department of Justice, the U.S. Department of Homeland Security, U.S Health and Human Services, Centers for Disease Control, Experis US (Manpower Group) and Deloitte to name a few. CloudMD will be able to augment IDYA4 network and provide its Livecare telemedicine solution as part of the portfolio of products and services available to IDYA4’ clients and partners. IDYA4 will act as a U.S. based partner and be selling the Livecare platform to associations nation-wide, providing distribution, infrastructure, on-boarding and IT support for Livecare in the U.S. As part of the Agreement and developing relationship, CloudMD will also look to include its broader portfolio, including Livecare Carts. These pre-configured Telehealth carts are used to achieve real-time diagnostic input and clinical evaluations for people in remote communities or those without immediate specialist clinical support and can be configured with the peripherals needed. These carts allow full remote high definition exams of patients for doctors who can be thousands of miles away. They can include Bluetooth stethoscopes, otoscopes, dermoscopes, oximeters, thermometers, blood pressure readers and opthalmascopes. Dr. Amit Mathur, President of CloudMD commented, “We are delighted to partner with IDYA4 Corp and utilize their experience and expertise to expand our Livecare platform into the United States. It’s important for us to continue to follow our disciplined strategy and having a trusted partner like IDYA4 Corp in the U.S. will be incredibly valuable for us to start introducing Livecare to their network of leading organizations across multiple sectors.” Sharad Rao, CEO of IDYA4 commented, “We are excited to partner with the CloudMD to bring their innovative Livecare platform to the United States. The Livecare platform will help better serve our clients and fulfill the growing demand of the Telehealth within Corrections, Healthcare markets and rural areas with focus on keeping our communities safe and healthier.” Other related developments from around the markets include: Telus Health (TSX:T)(NYSE:TU) announced the expansion of its Home Health Monitoring (HHM) solution so that nurses and other healthcare providers in British Columbia can digitally monitor more patients remotely while they recover from COVID-19. Launched in partnership with the B.C. Ministry of Health and local health authorities, this digital health dashboard enables healthcare providers to track the symptoms and provide medical help for more patients as they recover outside of hospitals in the comfort of their own homes. “As we face the immense challenge of COVID-19, TELUS Health is committed to working alongside BC’s healthcare leaders to expand the use of technology solutions like Home Health Monitoring to support more British Columbians while recovering at home,” said Darren Entwistle, president and CEO, TELUS. “By enabling clinicians to remotely observe the vitals of patients with COVID-19, as well as those who are vulnerable to the virus, and provide necessary interventions early, we can reduce exposure and also help to alleviate the pressure in hospital emergency rooms and clinics.” Easily accessible through a mobile device, the program sends daily prompts to the patient to report their biometrics such as temperature, physical symptoms and overall health condition. This provides crucial information on the status of a patient’s health to their clinicians who are regularly and remotely monitoring their well-being through a digital dashboard. Teladoc Health Inc. (NYSE:TDOC) reported financial results for the first quarter ending March 31, 2020. “In the first quarter of 2020 alone Teladoc Health delivered two million medical visits to people around the world, while simultaneously expanding access to millions of new members,” said Jason Gorevic, CEO. “As our clients and consumers have turned to us during these unprecedented times, our proven ability to meet their needs has elevated our global leadership role and accelerated our impact on the healthcare system overall.” CVS Health Corp. (NYSE:CVS) announced that as part of its COVID-19 relief efforts it is re-purposing a portion of its three-year, $40 million commitment to invest in California's health care delivery system. Nearly $1.5 million in grants will immediately help four local nonprofit organizations expand access to telehealth services, address food insecurity among California’s most vulnerable populations and support the state’s paramedics and EMTs. “Supporting local communities is part of our purpose of helping people on their path to better health,” said Kristen Miranda, California Market President for Aetna, a CVS Health company. “The role of our nonprofit partners has never been more important, which is why continued support is critical.” Walgreens Boots Alliance Inc. (NASDAQ:WBA) announced that its board of directors has declared a quarterly dividend of 45.75 cents per share, unchanged from the previous quarter and an increase of 4 percent from the year-ago quarter. The dividend is payable June 12, 2020, to stockholders of record as of May 20, 2020. Walgreens Boots Alliance and its predecessor company, Walgreen Co., have paid a dividend in 350 straight quarters (more than 87 years) and have raised the dividend for 44 consecutive years. Legal Disclaimer / Except for the historical information presented herein, matters discussed in this article contains forward-looking statements that are subject to certain risks and uncertainties that could cause actual results to differ materially from any future results, performance or achievements expressed or implied by such statements. Winning Media is not registered with any financial or securities regulatory authority and does not provide nor claims to provide investment advice or recommendations to readers of this release. For making specific investment decisions, readers should seek their own advice. Winning Media is only compensated for its services in the form of cash-based compensation. Pursuant to an agreement between Winning Media and CloudMD Software & Services Inc., Winning Media has been paid four thousand dollars for advertising and marketing services for CloudMD Software & Services Inc. We own ZERO shares of CloudMD Software & Services Inc. Please click here for full disclaimer. Contact Information: 2818047972 ty@WallStreetNation.com
Telemedicine Creating an Incredible $175 Billion Long-Term Opportunity May 07, 2020 - Baystreet.ca With the coronavirus making its rounds, telemedicine is under big demand. All as government and health officials advise against face to face meetings. It’s becoming so popular Global Market Insights estimates the market could be worth $175 billion by 2026. “Maintaining social distancing and self-quarantine are of key importance in containing the spread of corona virus. This have led to few countries taking stringent measures such as partial or complete lockdown. Which supports increasing adoption of telemedicine services to avail healthcare services. Also, various stringent regulations that were imposed on practicing telemedicine have also been relaxed. Such favorable government policies and growing inclination of patients towards virtual visits will propel the telemedicine market growth.” Markets and Markets estimates telehealth could grow from $25.4 billion in 2020 to more than $55.6 billion in 2025. While estimates vary, one thing is for certain. “Virtual care has moved to center stage and I would say it’s taken an irreversible leap forward,” said Teladoc Chief Executive Jason Gorevic. As demand increases some of the top companies leading the charge include CloudMD Software & Services Inc. (CSE:DOC)(OTCQB:DOCRF), Telus (TSX:T)(NYSE:TU), Teladoc Health Inc. (NYSE:TDOC), CVS Health Corp. (NYSE:CVS), and Walgreens Boots Alliance Inc. (NASDAQ:WBA). CloudMD Software & Services Inc. (CSE:DOC)(OTCQB:DOCRF) BREAKING NEWS: CloudMD Software & Services Inc, a telemedicine company revolutionizing the delivery of healthcare to patients, is excited to announce that it has entered into a Value Added Reseller Agreement with IDYA4 Corp., a leader in data interoperability and integration solutions within the government and private sectors. Under the Agreement, IDYA4 will resell CloudMD’s Livecare technology in the United States. The partnership opens up a significant opportunity for CloudMD to expand its telemedicine platform into the U.S., and IDYA4 subject matter expertise and established client network adds significant value to CloudMD’s expansion plan. The partnership further demonstrates CloudMD’s ability to tap into this multi-billion-dollar industry as an emerging leader in providing virtual healthcare. IDYA4 provides revolutionary technology solutions within public safety, corrections, health and human services sectors. IDYA4 has an impressive portfolio of clients including, the Bureau of Justice Assistance, U.S. Department of Justice, the U.S. Department of Homeland Security, U.S Health and Human Services, Centers for Disease Control, Experis US (Manpower Group) and Deloitte to name a few. CloudMD will be able to augment IDYA4 network and provide its Livecare telemedicine solution as part of the portfolio of products and services available to IDYA4’ clients and partners. IDYA4 will act as a U.S. based partner and be selling the Livecare platform to associations nation-wide, providing distribution, infrastructure, on-boarding and IT support for Livecare in the U.S. As part of the Agreement and developing relationship, CloudMD will also look to include its broader portfolio, including Livecare Carts. These pre-configured Telehealth carts are used to achieve real-time diagnostic input and clinical evaluations for people in remote communities or those without immediate specialist clinical support and can be configured with the peripherals needed. These carts allow full remote high definition exams of patients for doctors who can be thousands of miles away. They can include Bluetooth stethoscopes, otoscopes, dermoscopes, oximeters, thermometers, blood pressure readers and opthalmascopes. Dr. Amit Mathur, President of CloudMD commented, “We are delighted to partner with IDYA4 Corp and utilize their experience and expertise to expand our Livecare platform into the United States. It’s important for us to continue to follow our disciplined strategy and having a trusted partner like IDYA4 Corp in the U.S. will be incredibly valuable for us to start introducing Livecare to their network of leading organizations across multiple sectors.” Sharad Rao, CEO of IDYA4 commented, “We are excited to partner with the CloudMD to bring their innovative Livecare platform to the United States. The Livecare platform will help better serve our clients and fulfill the growing demand of the Telehealth within Corrections, Healthcare markets and rural areas with focus on keeping our communities safe and healthier.” Other related developments from around the markets include: Telus Health (TSX:T)(NYSE:TU) announced the expansion of its Home Health Monitoring (HHM) solution so that nurses and other healthcare providers in British Columbia can digitally monitor more patients remotely while they recover from COVID-19. Launched in partnership with the B.C. Ministry of Health and local health authorities, this digital health dashboard enables healthcare providers to track the symptoms and provide medical help for more patients as they recover outside of hospitals in the comfort of their own homes. “As we face the immense challenge of COVID-19, TELUS Health is committed to working alongside BC’s healthcare leaders to expand the use of technology solutions like Home Health Monitoring to support more British Columbians while recovering at home,” said Darren Entwistle, president and CEO, TELUS. “By enabling clinicians to remotely observe the vitals of patients with COVID-19, as well as those who are vulnerable to the virus, and provide necessary interventions early, we can reduce exposure and also help to alleviate the pressure in hospital emergency rooms and clinics.” Easily accessible through a mobile device, the program sends daily prompts to the patient to report their biometrics such as temperature, physical symptoms and overall health condition. This provides crucial information on the status of a patient’s health to their clinicians who are regularly and remotely monitoring their well-being through a digital dashboard. Teladoc Health Inc. (NYSE:TDOC) reported financial results for the first quarter ending March 31, 2020. “In the first quarter of 2020 alone Teladoc Health delivered two million medical visits to people around the world, while simultaneously expanding access to millions of new members,” said Jason Gorevic, CEO. “As our clients and consumers have turned to us during these unprecedented times, our proven ability to meet their needs has elevated our global leadership role and accelerated our impact on the healthcare system overall.” CVS Health Corp. (NYSE:CVS) announced that as part of its COVID-19 relief efforts it is re-purposing a portion of its three-year, $40 million commitment to invest in California's health care delivery system. Nearly $1.5 million in grants will immediately help four local nonprofit organizations expand access to telehealth services, address food insecurity among California’s most vulnerable populations and support the state’s paramedics and EMTs. “Supporting local communities is part of our purpose of helping people on their path to better health,” said Kristen Miranda, California Market President for Aetna, a CVS Health company. “The role of our nonprofit partners has never been more important, which is why continued support is critical.” Walgreens Boots Alliance Inc. (NASDAQ:WBA) announced that its board of directors has declared a quarterly dividend of 45.75 cents per share, unchanged from the previous quarter and an increase of 4 percent from the year-ago quarter. The dividend is payable June 12, 2020, to stockholders of record as of May 20, 2020. Walgreens Boots Alliance and its predecessor company, Walgreen Co., have paid a dividend in 350 straight quarters (more than 87 years) and have raised the dividend for 44 consecutive years. Legal Disclaimer / Except for the historical information presented herein, matters discussed in this article contains forward-looking statements that are subject to certain risks and uncertainties that could cause actual results to differ materially from any future results, performance or achievements expressed or implied by such statements. Winning Media is not registered with any financial or securities regulatory authority and does not provide nor claims to provide investment advice or recommendations to readers of this release. For making specific investment decisions, readers should seek their own advice. Winning Media is only compensated for its services in the form of cash-based compensation. Pursuant to an agreement between Winning Media and CloudMD Software & Services Inc., Winning Media has been paid four thousand dollars for advertising and marketing services for CloudMD Software & Services Inc. We own ZERO shares of CloudMD Software & Services Inc. Please click here for full disclaimer. Contact Information: 2818047972 ty@WallStreetNation.com